ZONEGRAN

Swiss trademark · 514177 · Word mark · In force

Register entry

Registration number
514177
Application number
53048/2003
Status
In force
Type
Word mark
Filed
Aug 25, 2003
Registered
Sep 17, 2003
Published
Oct 1, 2003
Protected until
Aug 25, 2033
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Anti-Epileptika; Anti-Konvulsiva; Arzneimittel zur Behandlung der Parkinsonschen Krankheit; Arzneimittel in Bezug auf das zentrale Nervensystem.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 19, 2024

    Publication

    Published in Swissreg on 19.11.2024

  2. Apr 4, 2024

    Agent removed

    Representative
    Hepp Wenger & Ryffel AG, Friedtalweg 5, 9500 Wil (removed)

    Published in Swissreg on 04.04.2024

  3. Apr 4, 2024

    Transferred

    Owner
    Sumitomo Pharma Co., Ltd., 6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-0045, Japan → Mercury Pharma Group Limited, Dashwood House, 69 Old Broad Street, London EC2M 1QS, United Kingdom
    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 04.04.2024

  4. May 3, 2023

    Renewed

    Published in Swissreg on 03.05.2023

  5. Jul 21, 2022

    Holder’s address changed

    Owner
    Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan → Sumitomo Pharma Co., Ltd., 6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-0045, Japan

    Published in Swissreg on 21.07.2022

  6. Jan 13, 2015

    Holder’s address changed

    Owner
    Dainippon Sumitomo Pharma Co., Ltd., 6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan → Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan

    Published in Swissreg on 13.01.2015

  7. Jul 10, 2013

    Renewed

    Published in Swissreg on 10.07.2013

  8. Jul 24, 2006

    Holder’s address changed

    Owner
    DAINIPPON PHARMACEUTICAL CO., LTD., 6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan → Dainippon Sumitomo Pharma Co., Ltd., 6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan

    Published in the SOGC no. 141 of 24.07.2006

2 earlier entries
  1. Jul 5, 2004

    Partly deleted

    LGS
    5, Anti-Epileptika; Anti-Konvulsiva; Arzneimittel zur Behandlung der Parkinsonschen Krankheit; Arzneimittel in Bezug auf das zentrale Nervensystem; Chemische Präparate für medizinische Zwecke; Chemische Präparate für pharmazeutische Zwecke; Arzneimittel; Arzneimittel für humanmedizinische Zwecke; Pharmazeutische Präparate. → 5, Anti-Epileptika; Anti-Konvulsiva; Arzneimittel zur Behandlung der Parkinsonschen Krankheit; Arzneimittel in Bezug auf das zentrale Nervensystem.
    International classification
    5 → 5

    Published in the SOGC no. 127 of 05.07.2004

  2. Oct 1, 2003

    Registered

    Published in the SOGC no. 188 of 01.10.2003

Parties

Holder

Mercury Pharma Group Limited

Dashwood House 69 Old Broad Street, London EC2M 1QS, GB

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.